首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1622938

電生理學市場：按產品、適應症、最終用戶和地區劃分，2024-2031 年

Electrophysiology Market By Product, Indication (Atrial Fibrillation, Atrial Flutter, Wolff-Parkinson-White Syndrome, aAtrioventricular Nodal Reentry Tachycardia), End-User, & Region for 2024-2031

出版日期: 2024年09月26日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

電生理學市場評估，2024-2031

全球心血管疾病（特別是心房顫動和心律不整）的盛行率不斷上升，需要先進的診斷和治療解決方案。特別是在已開發國家，隨著人口持續老化，電生理手術的需求不斷增加，預計2024年將達到55.7億美元，2031年將達到132.9億美元。

3D 測繪系統和微創導管的開發等技術進步也透過提高準確性和患者治療效果來推動市場擴張。此外，醫療保健支出的增加、心臟健康知識的提高以及導管消融手術的擴大使用正在進一步推動成熟經濟體和新興經濟體的市場擴張，預計從2024 年到2031 年將成長。年增率成長約11.47%。

電生理學市場定義/概述

電生理學是對活細胞和組織的電特性的研究，特別強調心律不整及其診斷和治療。典型應用包括辨識心房顫動和室性心搏過速，以及導管消融治療異常心跳。電生理學也用於植入起搏器和除顫器等醫療設備。電生理學的未來看起來很樂觀，3D 繪圖、人工智慧診斷和微創方法等進步可能會提高準確性和患者治療結果。

慢性病的增加會推動電生理學市場嗎？

慢性病，尤其是心血管疾病的盛行率不斷上升，是電生理學（EP）產業的主要推動因素。隨著全球心血管疾病負擔的增加，涉及心律問題的檢測和治療的電生理學變得越來越重要。根據世界衛生組織（WHO）2024年5月發佈的最新報告，心血管疾病仍是全球死亡的主要原因，佔所有死亡的31%。研究顯示，2020 年至 2023 年間，患有心房顫動（一種常見心律問題）的人數增加了 18%。

2024年3月，印度政府宣佈投資公共衛生基礎設施，以促進慢性病治療，包括興建配備先進電生理設備的專門心臟護理中心。這些法律發展和技術進步使慢性心臟病治療變得更加容易，並推動了電生理學市場的成長。

電生理設備成本的上漲會阻礙電生理市場的成長嗎？

電生理設備價格的上漲是阻礙電生理產業成長的重要因素。電生理設備中使用的先進技術，例如 3D 測繪系統、消融導管和心臟監測設備，通常價格昂貴，低收入者和小型醫療機構難以獲得。這種成本障礙阻礙了這些技術的廣泛採用，特別是在醫療保健預算有限的欠發達國家。此外，電生理治療的高昂費用可能會讓許多患者望而卻步，尤其是在保險覆蓋範圍和報銷選擇有限的地區。

特別是在較小的設施中，購買和維護昂貴的電生理設備的成本障礙可能會阻礙投資。因此，獲得最新診斷和治療技術的機會可能會被延遲或受到限制。因此，新興國家的醫療保健系統在擴大電生理服務覆蓋範圍方面可能面臨障礙，可能減緩整體市場成長。雖然技術突破和不斷增長的需求可以推動創新，但解決定價問題對於確保採用和市場擴張至關重要。

The increasing global prevalence of cardiovascular illnesses, particularly atrial fibrillation and arrhythmias, which require sophisticated diagnostic and therapeutic solutions. An aging population, particularly in developed nations, contributes to higher demand for electrophysiological operations is fuelling the USD 5.57 Billion in 2024 and reachingUSD 13.29 Billion by 2031.

Technological improvements, such as the development of 3D mapping systems and minimally invasive catheters, are also fuelling market expansion by enhancing accuracy and patient outcomes. Additionally, increased healthcare expenditure, greater knowledge of heart health, and the expanding use of catheter ablation procedures are further boosting the market's expansion across both established and emerging economies fueling market expected to grow at aCAGR of about 11.47% from 2024 to 2031.

Electrophysiology Market: Definition/ Overview

Electrophysiology is the study of the electrical properties of biological cells and tissues, with a particular emphasis on cardiac arrhythmias and their diagnosis and treatment. Its principal applications include identifying atrial fibrillation and ventricular tachycardia, as well as performing catheter ablation procedures to treat abnormal heartbeats. Electrophysiology is also used to implant medical devices such as pacemakers and defibrillators. The future of electrophysiology seems optimistic, with advances in 3D mapping, AI-powered diagnostics, and minimally invasive approaches likely to improve precision and patient outcomes.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will Rising Prevalence of Chronic Diseases Propelling the Electrophysiology Market?

The increasing prevalence of chronic diseases, particularly cardiovascular ailments, is a major driver of the Electrophysiology (EP) industry. Electrophysiology, which encompasses the detection and treatment of heart rhythm problems, is becoming increasingly important as the global burden of cardiovascular illnesses rises. In May 2024, According to the World Health Organization's most recent report, published, cardiovascular disease remains the top cause of mortality worldwide, accounting for 31% of all deaths. The survey stated that the number of persons living with atrial fibrillation, a common cardiac rhythm problem, grew by 18% between 2020 and 2023.

In March 2024, the Indian government announced investments in public health infrastructure to promote access to chronic illness treatments, including the construction of specialized cardiac care centers outfitted with sophisticated electrophysiology equipment. These legislative efforts, together with technology improvements, make chronic heart disease therapy more accessible and are significant drivers of the electrophysiology market's growth.

Will Rising High Cost of Electrophysiology Devices Hinder the Growth of the Electrophysiology Market?

The rising high cost of electrophysiological devices is a crucial factor that may impede the growth of the electrophysiology industry. Advanced technology employed in these devices, like as 3D mapping systems, ablation catheters, and cardiac monitoring instruments, are frequently expensive, making them less accessible in low-income areas and tiny healthcare facilities. This cost barrier prevents the widespread use of these technologies, particularly in underdeveloped countries with limited healthcare budgets. Furthermore, the high cost of electrophysiological treatments may render treatment options expensive for many patients, particularly in areas with limited insurance coverage or reimbursement options.

The cost barrier of obtaining and maintaining expensive electrophysiological equipment can deter investment, particularly in smaller facilities. This, in turn, may result in the delayed or limited use of modern diagnostic and therapeutic technologies. As a result, healthcare systems in developing nations face hurdles in expanding access to electrophysiological services, potentially slowing overall market growth. While technology breakthroughs and rising demand may propel innovation, resolving pricing issues is crucial to guaranteeing widespread use and market

Category-Wise Acumens

Will Increasing Demand of Ablation Catheters Propel the Electrophysiology Market?

The increasing need for ablation catheters is driving the electrophysiology market forward. Ablation catheters are critical for the treatment of arrhythmias, particularly atrial fibrillation, and their upgraded characteristics, such as improved navigation and ablation technology, are pushing their widespread use. For instance, in July 2024, Medtronic got FDA approval for a new ablation catheter with improved precision and safety features, demonstrating the increased investment in this technology. The increasing prevalence of cardiovascular illnesses, as well as the desire for minimally invasive procedures, are major contributors to the high demand for ablation catheters. Furthermore, advances in catheter technology, such as those released by Abbott and Boston Scientific, are projected to maintain the segment's growing momentum.

In August 2024, the US Department of Health and Human Services launched a new project targeted at boosting access to advanced cardiac care, such as ablation therapy, which is likely to drive market growth. This program complements larger initiatives to enhance cardiovascular care and save healthcare costs through novel medicines. The combination of technology improvements, regulatory backing, and increased healthcare spending is expected to sustain and drive the growth of the electrophysiology market, with ablation catheters playing a critical part in this expansion.

However, laboratory gadgets are the market's fastest-growing category. This expansion is being driven by an increased emphasis on improving diagnostic capabilities and the demand for improved technologies in electrophysiology labs. As healthcare providers and research institutes invest in cutting-edge laboratory equipment to improve diagnosis accuracy and treatment outcomes, this market is quickly rising.

Will Rising Sales through Hospitals and Cardiac Centers Fuel the Electrophysiology Market?

Rising sales from hospitals and cardiac centers are driving the electrophysiology market. These healthcare facilities are key purchasers of electrophysiology equipment, owing to the rising frequency of cardiac disorders and the demand for specialist treatment alternatives. For example, in June 2024, Boston Scientific established a strategic agreement with prominent institutions in North America to boost the usage of its latest electrophysiological equipment. This collaboration intends to improve patient outcomes and provide access to innovative electrophysiological treatments, suggesting a strong need in these crucial contexts.

In September 2024, the facilities for Medicare and Medicaid Services (CMS) revised its reimbursement policies to provide better coverage for electrophysiological procedures conducted in hospitals and specialist cardiac facilities. This legislative reform is expected to increase the use of advanced electrophysiological technology by lowering the cost obstacles for healthcare providers.

However, ambulatory surgery centers (ASCs) are the most rapidly expanding segment. ASCs provide a cost-effective and convenient option for outpatient procedures, such as electrophysiological tests and treatments. The transition to outpatient care, motivated by a desire to reduce healthcare costs and improve patient convenience, has resulted in growing use of electrophysiological services in ASCs. This tendency reflects a larger shift toward more efficient and accessible care approaches.

Country/Region-wise

Will Rising Significant Investments in Medical Technology in North America Drive the Electrophysiology Market?

Significant expenditures in medical technology in North America are generating tremendous growth in the electrophysiology (EP) sector. This trend is distinguished by increased investment for R&D, the use of modern technology, and supportive government policies. In May 2024, According to a report issued by the American Heart Association, investment in cardiovascular medical technology in North America reached USD 12.5 Billion in 2023, up 15% from the previous year, with electrophysiological devices accounting for 30% of this expenditure. This spike in financing has resulted in rapid advances in EP technology.

Furthermore, in April 2024, the Canadian government announced a multimillion-dollar investment in healthcare research and innovation, with a portion of the funding dedicated to enhancing cardiac care. These government measures, combined with private investments, are strengthening the North American electrophysiology market, positioning it as a key driver of growth and technological advancement in the area.

Will Increasing Healthcare Expenditure in Asia Pacific Propel the Electrophysiology Market?

The increasing healthcare expenditure in the Asia Pacific region is expected to considerably boost the electrophysiology market. As governments and business sectors in China, India, and Japan increase healthcare expenditure, there is a greater emphasis on strengthening cardiac care infrastructure, including the use of modern electrophysiological technologies. In June 2024, the Chinese government announced a significant increase in healthcare funding, with a focus on hospital modernization and the integration of cutting-edge medical equipment, such as electrophysiological devices. This investment is likely to increase the availability and accessibility of electrophysiological techniques for diagnosing and treating heart arrhythmias, hence propelling the industry ahead in the region.

In May 2024, the Indian government announced a national healthcare expansion plan that will increase public spending on sophisticated medical technology, particularly those used in cardiac treatment. This effort aims to address the country's growing prevalence of cardiovascular disorders. When combined with increased private healthcare investment, such as the establishment of specialist cardiac centers equipped with cutting-edge electrophysiology technology in major urban areas, the region is experiencing a large increase in demand for these technologies.

Competitive Landscape

The competitive landscape of the electrophysiology market is characterized by a mix of regional and emerging players alongside established companies. These smaller or regional firms focus on specialized areas such as niche cardiac diagnostic tools, catheter-based treatments, and mapping systems, catering to specific needs in various regions. Many are engaged in developing advanced technologies, such as AI-driven diagnostic tools and minimally invasive solutions, to compete with larger companies. Additionally, strategic partnerships, mergers, and acquisitions are common as these players seek to expand their product portfolios and geographical reach.

Some of the prominent players operating in the electrophysiology market include:

Acutus Medical, Inc.

APN Health LLC

Asahi Kasei Corp.

BIOTRONIK SE and Co. KG

Boston Scientific Corp.

CathRx Pty Ltd.

EP Solutions SA

EPMap System GmbH

GE Healthcare Technologies, Inc.

Imricor Medical Systems, Inc.

Japan Lifeline Co. Ltd.

Johnson and Johnson

Latest Developments

In May 2024, Philips introduces a new electrophysiological imaging platform with AI-driven analytics to improve diagnostic accuracy. This platform is intended to help electrophysiologists diagnose and treat complicated arrhythmias more efficiently.

In April 2024, The Stereotaxis announced a significant update to its robotic navigation system for electrophysiological operations. The updated system improves automation and precision, with the goal of reducing procedural time and increasing safety.

In February 2024, The Medtronic introduced a new range of electrophysiology diagnostic catheters including improved sensing technologies. These catheters are intended to provide more detailed and accurate electrophysiological data, hence enabling better clinical decision-making.

1 INTRODUCTION OF GLOBAL ELECTROPHYSIOLOGY MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
3.5 Market attractiveness

4 GLOBAL ELECTROPHYSIOLOGY MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL ELECTROPHYSIOLOGY MARKET, BY PRODUCT

5.1 Ablation Catheters
5.2 Laboratory Devices
5.3 Diagnostic Catheters
5.4 Access Devices
5.5 Others

6 GLOBAL ELECTROPHYSIOLOGY MARKET, BY INDICATION

6.1 Atrial Fibrillation (AF)
6.2 Atrial Flutter
6.3 Atrial tachycardia
6.4 Wolff-Parkinson-White Syndrome (WPW)
6.5 Atrioventricular Nodal Reentry Tachycardia (AVNRT)
6.6 Others

7 GLOBAL ELECTROPHYSIOLOGY MARKET, BY END-USER

7.1 Hospitals & Cardiac Centers
7.2 Ambulatory Surgery Centers
7.3 Others

8 GLOBAL ELECTROPHYSIOLOGY MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL ELECTROPHYSIOLOGY MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
9.4 ACE Matrix

10 COMPANY PROFILES

10.1 Acutus Medical Inc.
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 APN Health LLC
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Asahi Kasei Corp.
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 BIOTRONIK SE and Co. KG
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Boston Scientific Corp.
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 CathRx Pty Ltd.
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 EP Solutions SA
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 EPMap System GmbH
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 GE Healthcare Technologies Inc.
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Imricor Medical Systems Inc.
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
10.11 Imricor Medical Systems
- 10.11.1 Overview
- 10.11.2 Financial Performance
- 10.11.3 Product Outlook
- 10.11.4 Key Developments
10.12 OSYPKA AG
- 10.12.1 Overview
- 10.12.2 Financial Performance
- 10.12.3 Product Outlook
- 10.12.4 Key Developments